Clinician, Industry, and Research Speakers

Friday Night

David Chapman, PhD

Field Medical Director, Lundbeck
Presenting "Bexicaserin: An Investigational Therapy for Developmental and Epileptic Encephalopathies (DEEs)"

Joshua Hack

Doctoral Student, UCLA, BIO5 Institute at the University of Arizona
Presenting "Advancing Clinical Management of SCN8A-Related Disorder through Machine Learning"

Caeley M. Reever

PhD Candidate, Patel Lab, University of Virginia School of Medicine
Presenting "Utilizing Base Editing to Target SCN8A Epileptic Encephalopathy"

Ranmal A. Samarasinghe, MD, PhD

Assistant Professor, Department of Neurology, David Geffen SOM, UCLA
Presenting "From Cells to Seizures: What Brain Organoids are Teaching Us About SCN8A Epilepsy"

John Schreiber, MD

Associate Chief, Neurophysiology, Children's National Hospital

​Professor, Neurology and Pediatrics, The George Washington University School of Medicine
Presenting "SCN8A Consensus Guidelines"

Marcio Souza

Chief Executive Officer, Praxis Precision Medicines
Presenting "The EMBOLD Study"

Perry Spratt

Program Director, Regel Therapeutics
Presenting "CRISPR Activation for Sodium Channel Disorders: Insights from SCN2A Haploinsufficiency"

Moderators

Kacie Craig, MEd

Executive Director, The Cute Syndrome Foundation

Manoj Patel, PhD

Associate Professor, Department of Anesthesiology, University of Virginia

Family Education Presenters

Friday Afternoon

Raquel Miralles, PhD

Science & Research Director, SCN8A Alliance
​Presenting "SCN8A 101"

Madeleine J. Oudin, PhD

Tiampo Family Assistant Professor of Biomedical Engineering, Tufts University
Presenting "Understanding Treatment Strategies for SCN8A-Related Disorders"